potassium;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(6-methylpyrimidin-4-yl)phenyl]acetamide;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide;4-chloro-6-methylpyrimidine;oxido-oxidooxy-oxophosphanium;palladium;potassiopotassium;tetrakis(triphenylphosphane)

C126H124BClK3N12O10P5Pd — CID 158418975

IUPACpotassium;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(6-methylpyrimidin-4-yl)phenyl]acetamide;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide;4-chloro-6-methylpyrimidine;oxido-oxidooxy-oxophosphanium;palladium;potassiopotassium;tetrakis(triphenylphosphane)
SMILESCC(=O)N1CCN(c2ccc(NC(=O)Cc3ccc(-c4cc(C)ncn4)cc3)nc2)CC1.CC(=O)N1CCN(c2ccc(NC(=O)Cc3ccc(B4OC(C)(C)C(C)(C)O4)cc3)nc2)CC1.Cc1cc(Cl)ncn1.O=[P+]([O-])O[O-].[K+].[K][K].[Pd].c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1
InChIInChI=1S/C25H33BN4O4.C24H26N6O2.4C18H15P.C5H5ClN2.3K.HO4P.Pd/c1-18(31)29-12-14-30(15-13-29)21-10-11-22(27-17-21)28-23(32)16-19-6-8-20(9-7-19)26-33-24(2,3)25(4,5)34-26;1-17-13-22(27-16-26-17)20-5-3-19(4-6-20)14-24(32)28-23-8-7-21(15-25-23)30-11-9-29(10-12-30)18(2)31;4*1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;1-4-2-5(6)8-3-7-4;;;;1-4-5(2)3;/h6-11,17H,12-16H2,1-5H3,(H,27,28,32);3-8,13,15-16H,9-12,14H2,1-2H3,(H,25,28,32);4*1-15H;2-3H,1H3;;;;1H;/q;;;;;;;;;+1;;/p-1
InChIKeyHAGHEVHQMNUFAD-UHFFFAOYSA-M
MW2391.30 g/mol
LogP14.68
Rot. Bonds23

About potassium;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(6-methylpyrimidin-4-yl)phenyl]acetamide;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide;4-chloro-6-methylpyrimidine;oxido-oxidooxy-oxophosphanium;palladium;potassiopotassium;tetrakis(triphenylphosphane)

potassium;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(6-methylpyrimidin-4-yl)phenyl]acetamide;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide;4-chloro-6-methylpyrimidine;oxido-oxidooxy-oxophosphanium;palladium;potassiopotassium;tetrakis(triphenylphosphane) (PubChem CID 158418975) has the molecular formula C126H124BClK3N12O10P5Pd and a molecular weight of 2391.30 g/mol. Its IUPAC name is potassium;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(6-methylpyrimidin-4-yl)phenyl]acetamide;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide;4-chloro-6-methylpyrimidine;oxido-oxidooxy-oxophosphanium;palladium;potassiopotassium;tetrakis(triphenylphosphane).

Molecular Properties

Compound Namepotassium;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(6-methylpyrimidin-4-yl)phenyl]acetamide;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide;4-chloro-6-methylpyrimidine;oxido-oxidooxy-oxophosphanium;palladium;potassiopotassium;tetrakis(triphenylphosphane)
PubChem CID158418975
Molecular FormulaC126H124BClK3N12O10P5Pd
Molecular Weight2391.30 g/mol
Exact Mass2388.60
IUPAC Namepotassium;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(6-methylpyrimidin-4-yl)phenyl]acetamide;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide;4-chloro-6-methylpyrimidine;oxido-oxidooxy-oxophosphanium;palladium;potassiopotassium;tetrakis(triphenylphosphane)
SMILESCC(=O)N1CCN(c2ccc(NC(=O)Cc3ccc(-c4cc(C)ncn4)cc3)nc2)CC1.CC(=O)N1CCN(c2ccc(NC(=O)Cc3ccc(B4OC(C)(C)C(C)(C)O4)cc3)nc2)CC1.Cc1cc(Cl)ncn1.O=[P+]([O-])O[O-].[K+].[K][K].[Pd].c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1
InChIInChI=1S/C25H33BN4O4.C24H26N6O2.4C18H15P.C5H5ClN2.3K.HO4P.Pd/c1-18(31)29-12-14-30(15-13-29)21-10-11-22(27-17-21)28-23(32)16-19-6-8-20(9-7-19)26-33-24(2,3)25(4,5)34-26;1-17-13-22(27-16-26-17)20-5-3-19(4-6-20)14-24(32)28-23-8-7-21(15-25-23)30-11-9-29(10-12-30)18(2)31;4*1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;1-4-2-5(6)8-3-7-4;;;;1-4-5(2)3;/h6-11,17H,12-16H2,1-5H3,(H,27,28,32);3-8,13,15-16H,9-12,14H2,1-2H3,(H,25,28,32);4*1-15H;2-3H,1H3;;;;1H;/q;;;;;;;;;+1;;/p-1
InChIKeyHAGHEVHQMNUFAD-UHFFFAOYSA-M
XLogP14.68
TPSA273.52 Ų
H-Bond Donors2
H-Bond Acceptors18
Rotatable Bonds23
Heavy Atoms159
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002391.30
LogP ≤ 514.68
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'peroxide', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze potassium;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(6-methylpyrimidin-4-yl)phenyl]acetamide;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide;4-chloro-6-methylpyrimidine;oxido-oxidooxy-oxophosphanium;palladium;potassiopotassium;tetrakis(triphenylphosphane) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of potassium;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(6-methylpyrimidin-4-yl)phenyl]acetamide;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide;4-chloro-6-methylpyrimidine;oxido-oxidooxy-oxophosphanium;palladium;potassiopotassium;tetrakis(triphenylphosphane)?
The IUPAC name of potassium;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(6-methylpyrimidin-4-yl)phenyl]acetamide;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide;4-chloro-6-methylpyrimidine;oxido-oxidooxy-oxophosphanium;palladium;potassiopotassium;tetrakis(triphenylphosphane) (CID 158418975) is potassium;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(6-methylpyrimidin-4-yl)phenyl]acetamide;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide;4-chloro-6-methylpyrimidine;oxido-oxidooxy-oxophosphanium;palladium;potassiopotassium;tetrakis(triphenylphosphane).
What is the SMILES notation for potassium;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(6-methylpyrimidin-4-yl)phenyl]acetamide;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide;4-chloro-6-methylpyrimidine;oxido-oxidooxy-oxophosphanium;palladium;potassiopotassium;tetrakis(triphenylphosphane)?
The canonical SMILES for potassium;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(6-methylpyrimidin-4-yl)phenyl]acetamide;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide;4-chloro-6-methylpyrimidine;oxido-oxidooxy-oxophosphanium;palladium;potassiopotassium;tetrakis(triphenylphosphane) is CC(=O)N1CCN(c2ccc(NC(=O)Cc3ccc(-c4cc(C)ncn4)cc3)nc2)CC1.CC(=O)N1CCN(c2ccc(NC(=O)Cc3ccc(B4OC(C)(C)C(C)(C)O4)cc3)nc2)CC1.Cc1cc(Cl)ncn1.O=[P+]([O-])O[O-].[K+].[K][K].[Pd].c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.
What is the InChIKey of potassium;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(6-methylpyrimidin-4-yl)phenyl]acetamide;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide;4-chloro-6-methylpyrimidine;oxido-oxidooxy-oxophosphanium;palladium;potassiopotassium;tetrakis(triphenylphosphane)?
The InChIKey is HAGHEVHQMNUFAD-UHFFFAOYSA-M. The full InChI is InChI=1S/C25H33BN4O4.C24H26N6O2.4C18H15P.C5H5ClN2.3K.HO4P.Pd/c1-18(31)29-12-14-30(15-13-29)21-10-11-22(27-17-21)28-23(32)16-19-6-8-20(9-7-19)26-33-24(2,3)25(4,5)34-26;1-17-13-22(27-16-26-17)20-5-3-19(4-6-20)14-24(32)28-23-8-7-21(15-25-23)30-11-9-29(10-12-30)18(2)31;4*1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;1-4-2-5(6)8-3-7-4;;;;1-4-5(2)3;/h6-11,17H,12-16H2,1-5H3,(H,27,28,32);3-8,13,15-16H,9-12,14H2,1-2H3,(H,25,28,32);4*1-15H;2-3H,1H3;;;;1H;/q;;;;;;;;;+1;;/p-1.
What are the key properties of potassium;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(6-methylpyrimidin-4-yl)phenyl]acetamide;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide;4-chloro-6-methylpyrimidine;oxido-oxidooxy-oxophosphanium;palladium;potassiopotassium;tetrakis(triphenylphosphane)?
potassium;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(6-methylpyrimidin-4-yl)phenyl]acetamide;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide;4-chloro-6-methylpyrimidine;oxido-oxidooxy-oxophosphanium;palladium;potassiopotassium;tetrakis(triphenylphosphane) has a molecular weight of 2391.30 g/mol, XLogP of 14.68, 23 rotatable bonds, 2 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for potassium;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(6-methylpyrimidin-4-yl)phenyl]acetamide;N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide;4-chloro-6-methylpyrimidine;oxido-oxidooxy-oxophosphanium;palladium;potassiopotassium;tetrakis(triphenylphosphane) is sourced from PubChem (CID 158418975), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).